Navigation Links
CutisPharma Homogeneity and Stability Study for Mouthwash Compounding Kits Presented at NERDG Meeting
Date:5/15/2012

WOBURN, Mass., May 15, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the presentation of homogeneity and stability studies for compounded formulations of several "Magic Mouthwash" suspensions using FIRST®- Unit- of- use Prescription Compounding Kits.  The poster presentation, by Anisa Gandhi, was at the April 20th American Association of Pharmaceutical Scientists, Northeast Regional Discussion Group (NERDG) Regional Meeting.

"Magic Mouthwash" is commonly prescribed by physicians nationwide.  The purpose behind magic mouthwash is to combine various ingredients with different advantages depending on the patient's symptoms.  Currently magic mouthwash is extemporaneously prepared or is prepared using FIRST® - Magic Mouthwash Compounding Kits.

The active ingredients used in these FIRST® Magic Mouthwash kits are comparable to those found in the most routinely prescribed "Magic Mouthwash" formulations.  These active ingredients are: diphenhydramine hydrochloride, lidocaine hydrochloride, and modified Maalox® in FIRST® - Mouthwash BLM; diphenhydramine hydrochloride, lidocaine hydrochloride, and nystatin in FIRST®  -BXN Mouthwash; diphenhydramine hydrochloride, hydrocortisone, and nystatin in FIRST®  - Duke's Mouthwash; and diphenhydramine hydrochloride, hydrocortisone, nystatin, and tetracycline in FIRST®  - Mary's Mouthwash.

Ms. Gandhi's presentation demonstrated that FIRST®  -Mouthwash Kits are uniform in nature for active ingredients.  FIRST®  Magic Mouthwash Kits are convenient with reliable stability and uniformity data, whereas, the traditional compounding process generally does not have this data available.

FIRST® products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction.  Using FIRST® Mouthwash kits, the pharmacist can compound a prescription with accuracy faster than those prepared in the conventional way.  A single NDC number assigned for the entire kit facilitates the third party reimbursement process, and reduces audit- related adjustments.

CutisPharma now has twenty proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, six Magic Mouthwash kits, three omeprazole suspension kits, and three lansoprazole suspension kits.  Several more compounding kits are in the planning stages. The use of FIRST® Unit-of-Use Prescription Compounding Kits facilitates compliance with United States Pharmacopeia (USP) Chapter <795>.

"CutisPharma is committed to maintaining the scientific integrity of the products it develops and commercializes.  Studies of this nature also demonstrate the scientific reliability of FIRST® products, as well as confirm their user-friendliness and time-saving benefits" said Dr. Indu Muni, President  & CEO of CutisPharma.

About CutisPharma
CutisPharma, Inc. based in Woburn, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.

For more information please visit our website at www.cutispharma.com.


'/>"/>
SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
2. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
3. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
4. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
5. CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
6. Soligenix Announces Publication of Positive Stability Results with RiVax(TM), its Vaccine Against Ricin Toxin
7. Senesco Presents Pre-Clinical Stability and Biological Activity Data on SNS-01 at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
8. ADVENTRX Announces 9-Month Stability Data Results for ANX-530
9. Bristol-Myers Squibb and WuXi PharmaTech Announce Collaboration for a New Analytical and Stability Testing Facility
10. Stability Testing Course is Taking the Online Training Format by Storm!
11. Ethicon Endo-Surgery Introduces First Powered Endocutter with Enhanced System-Wide Compression and Stability, Allowing Surgeons Greater Control in Laparoscopic Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Inc. (NYSE: DPLO ) is pleased to announce the promotion of Paul Urick ... 23, 2016. To learn more about our ... ... ... In his redefined ...
(Date:2/12/2016)... 12, 2016   HeartWare International, Inc . (NASDAQ: ... webcast to discuss its financial results for the three ... February 25, 2016 at 8:00 a.m. ET.  The company ... conference call and webcast.  On the conference call and ... from the fourth quarter and business outlook.   ...
(Date:2/12/2016)... 12, 2016  Sequent Medical, Inc. announced today that ... evaluate the safety and effectiveness of the WEB™ Aneurysm ... intracranial aneurysms.  Prof Laurent Spelle , MD, Head ... Paris, France and Principal Investigator of the ... France and Germany.  Although patients with ruptured ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 , ... The law firm ... and Evangeline Parishes. The purpose of these scholarships is to encourage applicants to ... individuals to seek employment within these two parishes. , “We have available jobs ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... to funding innovative lymphoma research and serving the lymphoma community through a comprehensive ... members of South Florida’s philanthropic community at its 10th anniversary Fashion Luncheon on ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination Drug ... p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination products ... increased attention from all stakeholders in the development of new chemical entities. , ...
(Date:2/12/2016)... ... , ... As a former television executive, owner Tal Rabinowitz knows how stressful ... decompress, Rabinowitz found herself drawn to a casual meditation class while working at NBC ... implementing a 20-minute-per-day meditation practice with her team. After her tenure at NBC, she ...
(Date:2/12/2016)... ... February 12, 2016 , ... T.E.N., a technology and information ... ISE Southeast Awards 2016. Finalists and winners of the ISE® Awards for both ... and Awards Gala on March 15, 2016 at the Westin Peachtree Plaza, Atlanta. ...
Breaking Medicine News(10 mins):